14名患有胺转基因酶缺乏症 (PMM2-CDG) 的个体的神经发育特征
Tara Weixel1,2, Dee Adedipe3,4, Glennis Muldoon3,5
1National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.
Journal of inherited metabolic disease
|August 6, 2024
概括
糖突变酶2-血糖化先天性障碍 (PMM2-CDG) 导致复杂的神经发育问题,包括智力障碍和延迟的里程碑. 这项研究量化了这些障碍,以指导患者管理.
科学领域:
- 生物化学 生物化学
- 遗传学 是一个遗传学.
- 神经科学是一个神经科学.
背景情况:
- PMM2-CDG是最常见的血糖酶化先天性疾病,是自体递归遗传的.
- 它在婴儿期呈现出多系统性参与,影响全球1000多个个体.
- 关于PMM2-CDG的神经发育方面的自然史数据有限.
研究的目的:
- 进行深度表型的前性研究,包括对PMM2-CDG进行神经发育评估.
- 系统量化患有PMM2-CDG的个体的神经发育特征.
- 扩大对PMM2-CDG损伤的理解,并为管理策略提供信息.
主要方法:
- 前性研究 (NCT02089789) 涉及14名参与者 (年龄在2-33岁) 确诊的PMM2-CDG.
- 将全面的神经发育评估纳入深度表型化协议中.
- 分析临床特征,包括生长,运动,语言和认知功能.
主要成果:
- 参与者表现出神经发育障碍,生长迟缓,低血压,小脑缩,外围神经病变,运动障碍以及眼科/听力差异.
- 所有参与者都符合智力障碍或全球发育迟缓的标准.
- 大多数参与者推迟了毛发动机和语言里程碑,行走和口头表达有限.
结论:
- PMM2-CDG具有复杂的神经发育特征,其特点是智力障碍和多系统参与.
- 这项研究提供了PMM2-CDG神经发育障碍的系统量化.
- 这些发现将有助于指导PMM2-CDG.患者的临床管理策略.
相关概念视频
Inborn Errors of Metabolism
148
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
148
Pedigree Analysis
84.2K
Overview
84.2K
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K


